Hence, early intervention with molecules or mixtures of molecules capable of exerting a dual effect, improving insulin sensitivity and promoting better functioning of the β cell would result in better glycemic control in patients with T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.